Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminants
Related Experiment Video
Updated: Oct 30, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
1National Institute of Molecular Biology and Biotechnology (BIOTECH), University of the Philippines at Los Banos, Laguna.
Abstract:
A subunit vaccine against haemorrhagic septicaemia (HS), the principal killer disease in ruminants, especially cattle and carabao, in the Philippines, has been developed. Using capsules of Pasteurella multocida Group B as an active component of the vaccine, it gave solid protection against challenge with live organism in mice. An active calf protection test showed that in 24 hours, animals vaccinated with plain saline died after challenge compared to those given the subunit vaccine which survive the challenge dose. Using 104 cattle from a farm, the field trial of the HS subunit vaccine showed that the antibody titre was high for up to 14 months. A high titer is an indication of protection.
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccines
Vaccinations
Vaccine Production
Smallpox
Viral Structure

